Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biogen, Inc. (NQ: BIIB )

270.28 USD -3.56 (-1.30%)
Official Closing Price Updated: 5:19 PM EST, Jan 20, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Biogen, Inc.

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Interesting BIIB Put And Call Options For April 2021
Investors in Biogen Inc (BIIB) saw new options become available this week, for the April 2021 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time... 
Tags Stocks
From Market News Video
TQQQ, CSX, ILMN, BIIB: Large Outflows Detected at ETF
Symbols mentioned in this story: TQQQ, CSX, ILMN, BIIB Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
Apple Becomes First Ever $2trn Company But Markets Wobble On Fed Uncertainty
Markets pulled back overnight in the US and Asia, with futures indicating more losses are likely today, after a lack of clear policy direction from the Fed triggered some profit taking. 
Tags Basic Materials / Commodities Transportation Services
From Blogs - TalkMarkets
Noteworthy Wednesday Option Activity: MCD, BIIB, YUM
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in McDonald's Corp (MCD), where a total volume of 13,688 contracts has been traded thus far... 
Tags Stocks
From Market News Video
101 Biggest Movers From Friday
Gainers Conduent Incorporated (NASDAQ: CNDT) shares climbed 82.7% to close at $4.13 on Friday after the company reported ... 
Tags ISSC TRUE JOB
From Benzinga
Week In Review: BioKangtai Acquires China Rights To AstraZeneca's COVID-19 Vaccine
BioKangtai, a Guangdong vaccine company, in-licensed rights to develop, manufacture, and market AstraZeneca's COVID-19 vaccine in China. Biogen announced a $2 billion deal to partner Denali... 
Tags Stocks / Equities Healthcare Pharma/Biotech
From Blogs - TalkMarkets
'Fast Money' Picks For August 10
On CNBC's "Fast Money Final Trade," Bonawyn Eison said that he wants to fade the rally in Carnival Corp (NYSE: ... 
Tags CCL Jeff Mills Media
From Benzinga
Week in Review: BioKangtai Acquires China Rights to AstraZeneca's COVID-19 Vaccine
COVID-19 Pandemic • BioKangtai, a Guangdong vaccine company, in-licensed rights to develop, manufacture and market AstraZeneca's COVID-19 vaccine in China; • Shanghai Fosun Pharma has dosed the first... 
From ChinaBio® Today
FDA Approves First Oral Treatment for Spinal Muscular Atrophy
Roche and PTC Therapeutics will challenge Novartis and Biogen with competitive pricing for Evrysdi. 
Tags NVS Market News RHHB/Y
From Motley Fool
Biogen Stock Surges As FDA Fast-Tracks Alzheimer's Drug Application
Biogen stock surged after the firm said the FDA has decided to fast track its application to bring Alzheimer's disease drug aducanumab to market. 
From Investor's Business Daily
Why Biogen Stock Surged Today
The drugmaker hopes its experimental new therapy could change the lives of people who struggle with Alzheimer’s disease. 
Tags BIIB Market News
From Motley Fool
Notable Friday Option Activity: BIIB, FDX, AAP
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Biogen Inc (BIIB), where a total volume of 24,936 contracts has been traded thus far... 
Tags Stocks
From Market News Video
80 Stocks Moving In Friday's Mid-Day Session
Gainers Conduent Incorporated (NASDAQ: CNDT) shares jumped 81.2% to $4.0950 after the company reported better-than-expected Q2 ... 
Tags ADTX PACB CARV
From Benzinga
BIIB Crosses Above Key Moving Average Level
In trading on Friday, shares of Biogen Inc (BIIB) crossed above their 200 day moving average of $296.77, changing hands as high as $312.00 per share. Biogen Inc shares are currently trading up about... 
Tags Stocks
From Market News Video
Biogen Soars As FDA Accepts Alzheimer's Drug For Review In 'Next Stage Of Aducanumab Saga'
Biogen Inc's (NASDAQ: BIIB) investigational Alzheimer's drug aducanumab — a drug forwhich the company halted studies ... 
Tags Trading Ideas alzheimer's Aducanumab
From Benzinga
Biogen Stock Surges As FDA Fast Tracks Alzheimer's Drug Application
Biogen stock surged after the firm said the FDA has decided to fast track its application to bring Alzheimer's disease drug aducanumab to market. 
From Investor's Business Daily
Nasdaq 100 Movers: ILMN, BIIB
In early trading on Friday, shares of Biogen topped the list of the day's best performing components of the Nasdaq 100 index, trading up 9.0%. Year to date, Biogen registers a 2.0% gain. 
Tags Stocks
From Market News Video
S&P 500 Movers: ILMN, BIIB
In early trading on Friday, shares of Biogen topped the list of the day's best performing components of the S&P 500 index, trading up 10.6%. Year to date, Biogen registers a 3.5% gain. 
Tags Stocks
From Market News Video
Dow Jones Today, Futures Ease Ahead Of July Payrolls; China Stocks Dive On Trump Order; Biogen Gets FDA Nod
Stock futures were lower Friday, ahead of July payrolls data, as China stocks dived and IBM fell furthest on the Dow Jones today. 
From Investor's Business Daily
Why Shares of Denali Therapeutics Are Skyrocketing
Shares of Denali Therapeutics Inc (NASDAQ: DNLI) are racing toward their 52-week high following a clinical pipeline update concerning ... 
Tags Market News Movers Biotech
From Benzinga
Biogen, Denali Announce Billion-Dollar Collaboration On Parkinson's Treatment
Biogen and Denali Therapeutics early Thursday announced a billion-dollar collaboration to move forward on testing on a Denali treatment for Parkinson's disease, sending DNLI stock soaring. 
From Investor's Business Daily
Biogen Enters $2 Billion Deal to Co-Develop Parkinson's Candidate in US and China
Biogen announced a $2 billion blockbuster deal to partner Denali Therapeutics' potential Parkinson's Disease therapy. In exchange for its $1 billion in upfront payments and $1 billion in milestones,... 
From ChinaBio® Today
Biogen Takes Over #138 Spot From Baxter International
In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Biogen Inc (BIIB) has taken over the #138 spot from Baxter International Inc (BAX), according to... 
Tags Stocks
From Market News Video
Benzinga's Bulls And Bears Of The Week: Apple, Boeing, Facebook And More
Benzinga has examined the prospects for many investor favorite stocks over the past week. This week's bullish calls included ... 
Tags Apple Tesla FB
From Benzinga
Noteworthy Tuesday Option Activity: AKAM, BIIB, GOOG
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Akamai Technologies Inc (AKAM), where a total volume of 10,723 contracts has been... 
Tags Stocks
From Market News Video
If You Invested $1,000 in Biogen During the Last Recession, This Is How Much You Would Have Today
This stock's value has quintupled since the last recession. 
Tags BIIB Market News
From Motley Fool
My Internet Woes As Gold Grows
While suffering with my own website being knocked offline, I'm thrilled to ride the gold wave, as my gold investments continue to grow. Here's how my gold, pharma, energy and other stock buys are... 
Tags Consumer Goods Pharma/Biotech Energy
From Blogs - TalkMarkets
Morgan Stanley double-upgrades Biogen and says the stock can surge another 30% (BIIB)
From Business Insider
Morgan Stanley Double Upgrades Biogen, Says Alzheimer's Opportunity Ahead
Although Biogen Inc (NASDAQ: BIIB) will face generic competitors for Tecfidera in the near term, the pricing in of aducanumab success ... 
Tags BIIB General Analyst Ratings
From Benzinga
We Did The Math MGV Can Go To $84
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.